PNC Financial Services Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,236
Closed -$417K 5087
2025
Q2
$417K Buy
4,236
+261
+7% +$24.7K ﹤0.01% 1683
2025
Q1
$368K Buy
3,975
+36
+0.9% +$3.32K ﹤0.01% 1745
2024
Q4
$358K Buy
3,939
+33
+0.8% +$3.03K ﹤0.01% 1785
2024
Q3
$377K Sell
3,906
-213
-5% -$20.8K ﹤0.01% 1732
2024
Q2
$378K Sell
4,119
-80
-2% -$7.42K ﹤0.01% 1686
2024
Q1
$387K Sell
4,199
-2,287
-35% -$214K ﹤0.01% 1695
2023
Q4
$617K Sell
6,486
-186
-3% -$17.4K ﹤0.01% 1385
2023
Q3
$623K Sell
6,672
-1,593
-19% -$147K ﹤0.01% 1355
2023
Q2
$756K Sell
8,265
-3,463
-30% -$284K ﹤0.01% 1304
2023
Q1
$863K Buy
11,728
+370
+3% +$32K ﹤0.01% 1212
2022
Q4
$949K Buy
11,358
+1,073
+10% +$96.7K ﹤0.01% 1150
2022
Q3
$995K Buy
10,285
+147
+1% +$17.5K ﹤0.01% 1125
2022
Q2
$1.06M Buy
10,138
+1,123
+12% +$143K ﹤0.01% 1118
2022
Q1
$1.55M Sell
9,015
-75
-0.8% -$11.2K ﹤0.01% 1032
2021
Q4
$1.47M Buy
9,090
+1,674
+23% +$269K ﹤0.01% 1079
2021
Q3
$1.11M Buy
7,416
+483
+7% +$100K ﹤0.01% 1143
2021
Q2
$1.7M Sell
6,933
-274
-4% -$71.9K ﹤0.01% 985
2021
Q1
$1.91M Buy
7,207
+323
+5% +$91.1K ﹤0.01% 901
2020
Q4
$2.02M Buy
6,884
+7
+0.1% +$1.79K ﹤0.01% 836
2020
Q3
$1.63M Sell
6,877
-1,082
-14% -$246K ﹤0.01% 853
2020
Q2
$1.58M Buy
7,959
+876
+12% +$163K ﹤0.01% 864
2020
Q1
$1.3M Buy
7,083
+2,348
+50% +$418K ﹤0.01% 870
2019
Q4
$791K Sell
4,735
-464
-9% -$69K ﹤0.01% 1202
2019
Q3
$682K Sell
5,199
-336
-6% -$43.7K ﹤0.01% 1430
2019
Q2
$671K Buy
5,535
+1,973
+55% +$234K ﹤0.01% 1463
2019
Q1
$439K Sell
3,562
-361
-9% -$45.3K ﹤0.01% 1701
2018
Q4
$459K Buy
3,923
+322
+9% +$38K ﹤0.01% 1597
2018
Q3
$450K Buy
3,601
+26
+0.7% +$2.87K ﹤0.01% 1724
2018
Q2
$306K Buy
3,575
+237
+7% +$17.4K ﹤0.01% 1931
2018
Q1
$201K Sell
3,338
-6
-0.2% -$342 ﹤0.01% 2158
2017
Q4
$176K Buy
3,344
+2,781
+494% +$147K ﹤0.01% 2259
2017
Q3
$32K Buy
563
+357
+173% +$18.9K ﹤0.01% 3145
2017
Q2
$13K Buy
206
+78
+61% +$4.54K ﹤0.01% 3484
2017
Q1
$7K Buy
+128
New +$6.11K ﹤0.01% 3633
2016
Q3
Sell
-176
Closed -$9K 3962
2016
Q2
$9K Sell
176
-7
-4% -$353 ﹤0.01% 3588
2016
Q1
$9K Buy
183
+6
+3% +$232 ﹤0.01% 3606
2015
Q4
$7K Sell
177
-1,000
-85% -$40K ﹤0.01% 3723
2015
Q3
$45K Buy
1,177
+1,006
+588% +$42.4K ﹤0.01% 2920
2015
Q2
$7K Buy
171
+73
+74% +$2.27K ﹤0.01% 3929
2015
Q1
$3K Sell
98
-352
-78% -$9.93K ﹤0.01% 4161
2014
Q4
$14K Hold
450
﹤0.01% 3259
2014
Q3
$8K Sell
450
-220
-33% -$4.25K ﹤0.01% 3324
2014
Q2
$12K Hold
670
﹤0.01% 3079
2014
Q1
$10K Buy
670
+120
+22% +$1.85K ﹤0.01% 3057
2013
Q4
$8K Sell
550
-896
-62% -$14.4K ﹤0.01% 3033
2013
Q3
$25K Sell
1,446
-1,247
-46% -$18.5K ﹤0.01% 2750
2013
Q2
$32K Buy
+2,693
New +$30.8K ﹤0.01% 2564

Other funds holding AMED

PNC Financial Services Group's AMED Position: Q3 2025 in Review

PNC Financial Services Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,236 shares — an estimated $417K sold.

PNC Financial Services Group first reported a position in AMED in Q2 2013 and held it in 47 quarters. The position peaked at $2.02M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • PNC Financial Services Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 4,236 Amedisys shares in Q3 2025, an estimated $417K.
  • PNC Financial Services Group first reported a position in Amedisys in Q2 2013 and held it in 47 quarters.
  • PNC Financial Services Group's Amedisys position peaked at $2.02M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.